First Venture Technologies Corp.

First Venture Technologies Corp.

April 12, 2007 09:00 ET

First Venture Reports Product Trials in Canada

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - April 12, 2007) - First Venture Technologies Corp. (TSX VENTURE:FEB) reports that the company's proprietary yeasts are being trialed by the Canadian wine industry.

"Having recently received Canadian government approval for the manufacture and use of our ethyl carbamate minimizing yeast in Canada, we are very pleased to have the Canadian wine industry's support to trial our products," said Andy Starr, Director of Marketing and Business Development of First Venture Yeast Products, Inc., a wholly owned subsidiary of First Venture Technologies Corp.

It is expected that these trials will provide similar fermentation and wine product results as determined in lab trials conducted at the Wine Research Centre at The University of British Columbia, as well as commercial trials run this past crush in the USA. The company's commercial trial partners seek to confirm that wines produced with First Venture's proprietary yeasts do not differ in terms of sensory attributes and fermentation kinetics from wines produced with comparative commercial yeast strains.

"It is gratifying that Canadian wine producers recognize the benefits that our proprietary yeasts can provide in minimizing an ethyl carbamate contaminant occurrence in their wine products, and we are pleased to be able to accommodate their requests for product trials," added Mr. Starr. "As with inquiries that we are receiving from wine and spirits producers from other parts of the world, their interest is made even more pertinent by the recent news of the World Health Organization's International Agency for Research on Cancer's reclassification of ethyl carbamate from a Group 2B possible human carcinogen now to a Group 2A probable human carcinogen."

First Venture is expanding its selection of proprietary yeast strains from which producers of wine and other food and beverage products may choose based on their product and manufacturing preferences. Product applications are underway with Canadian federal government agencies for manufacturing and usage approvals in Canada for a number of additional ethyl carbamate yeast strains.


Geoff Lee, CFO & Director of Regional Development


First Venture is a biotechnology company that develops and commercializes advanced yeast products. The company is currently commercializing a platform yeast technology that substantially reduces the formation of a known carcinogen, ethyl carbamate (or urethane) from food products and alcoholic beverages. The company has licensed the exclusive worldwide rights to the technology from The University of British Columbia (UBC), and is developing the technology in partnership with UBC's world-renowned Wine Research Centre.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information